Proactive Investor commented "Gaining a cornerstone shareholder of the ilk of Sprott Group, at a premium, is a sizeable vote of confidence in the future prospects of BGS"
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%